The Valley Desk

NCT01261312 · Interventional trial

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Overall registry status Completed

Phase 1 · Phase 2

Conditions AML, CMML, MDS

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov